BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8847567)

  • 21. Effect of 7-hydroxystaurosporine on glioblastoma cell invasion and migration.
    Meng QH; Zhou LX; Luo JL; Cao JP; Tong J; Fan SJ
    Acta Pharmacol Sin; 2005 Apr; 26(4):492-9. PubMed ID: 15780200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C.
    Akinaga S; Nomura K; Gomi K; Okabe M
    Cancer Chemother Pharmacol; 1993; 32(3):183-9. PubMed ID: 8500222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
    Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
    Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the efficacy of 7-hydroxystaurosporine (UCN-01) and other staurosporine analogs to abrogate cisplatin-induced cell cycle arrest in human breast cancer cell lines.
    Lee SI; Brown MK; Eastman A
    Biochem Pharmacol; 1999 Dec; 58(11):1713-21. PubMed ID: 10571245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of apoptosis in rat thymocytes by analogs of staurosporine: lack of direct association with inhibition of protein kinase C.
    Harkin ST; Cohen GM; Gescher A
    Mol Pharmacol; 1998 Oct; 54(4):663-70. PubMed ID: 9765509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological deficit after carotid infusion of cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) for malignant glioma: an analysis of risk factors.
    Kapp JP; Sanford RA
    Neurosurgery; 1986 Nov; 19(5):779-83. PubMed ID: 3785625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UCN-01 dose-dependent inhibition of normal hyperproliferative cells in mice.
    Redkar AA; Meadows GG; Daoud SS
    Int J Oncol; 2001 Jul; 19(1):193-9. PubMed ID: 11408942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variations in response of human brain tumors to BCNU in vitro.
    Kornblith PL; Szypko PE
    J Neurosurg; 1978 Apr; 48(4):580-6. PubMed ID: 632883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 7-Hydroxystaurosporine (UCN-01) induces apoptosis in human colon carcinoma and leukemia cells independently of p53.
    Shao RG; Shimizu T; Pommier Y
    Exp Cell Res; 1997 Aug; 234(2):388-97. PubMed ID: 9260909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis of human glioma cells in response to calphostin C, a specific protein kinase C inhibitor.
    Ikemoto H; Tani E; Matsumoto T; Nakano A; Furuyama J
    J Neurosurg; 1995 Dec; 83(6):1008-16. PubMed ID: 7490614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity of signal transduction mechanisms in human basophils and human skin mast cells. II. Effects of 7-O-methyl-UCN-01, NPC 15437 and bryostatin 1 and 2, four protein kinase C-modulatory agents, on mediator release.
    Noll T; Dieckmann D; Gibbs BF; Nitschke M; Albrecht C; Vollrath I; Tamaoki T; Wolff HH; Amon U
    Biol Signals; 1997; 6(1):1-10. PubMed ID: 9098518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of protein kinase C (PKC) in the evolution and proliferation of malignant gliomas, and the application of PKC inhibition as a novel approach to anti-glioma therapy.
    Bredel M; Pollack IF
    Acta Neurochir (Wien); 1997; 139(11):1000-13. PubMed ID: 9442212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF; Erff M; Ashkenazi A
    Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
    Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM
    Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UCN-01, 7-hydroxyl-staurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line.
    Kawakami K; Futami H; Takahara J; Yamaguchi K
    Biochem Biophys Res Commun; 1996 Feb; 219(3):778-83. PubMed ID: 8645257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro.
    Pollack IF; Randall MS; Kristofik MP; Kelly RH; Selker RG; Vertosick FT
    Cancer Res; 1990 Nov; 50(22):7134-8. PubMed ID: 2224848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function.
    Shao RG; Cao CX; Shimizu T; O'Connor PM; Kohn KW; Pommier Y
    Cancer Res; 1997 Sep; 57(18):4029-35. PubMed ID: 9307289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 7-hydroxystaurosporine (UCN-01) and ionizing radiation combine to inhibit the growth of Bcl-2-overexpressing U937 leukemia cells through a non-apoptotic mechanism.
    Cartee L; Sankala H; Davis C; Smith R; Maggio S; Lin PS; Dent P; Grant S
    Int J Oncol; 2002 Aug; 21(2):351-9. PubMed ID: 12118331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro.
    Couldwell WT; Uhm JH; Antel JP; Yong VW
    Neurosurgery; 1991 Dec; 29(6):880-6; discussion 886-7. PubMed ID: 1758601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodality therapy: radiation and continuous concomitant cis-platinum and PKC inhibition in a cervical carcinoma model.
    Sommers GM; Alfieri AA
    Cancer Invest; 1998; 16(7):462-70. PubMed ID: 9774953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.